Research ExplorerPublicationsManagement of patients with multidrug-resistant/extensively ...

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement

Standard

Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. / Lange, Christoph; Abubakar, Ibrahim; Alffenaar, Jan-Willem C; Bothamley, Graham; Caminero, Jose A; Carvalho, Anna Cristina C; Chang, Kwok-Chiu; Codecasa, Luigi; Correia, Ana; Crudu, Valeriu; Davies, Peter; Dedicoat, Martin; Drobniewski, Francis; Duarte, Raquel; Ehlers, Cordula; Erkens, Connie; Goletti, Delia; Günther, Gunar; Ibraim, Elmira; Kampmann, Beate; Kuksa, Liga; de Lange, Wiel; van Leth, Frank; van Lunzen, Jan; Matteelli, Alberto; Menzies, Dick; Monedero, Ignacio; Richter, Elvira; Rüsch-Gerdes, Sabine; Sandgren, Andreas; Scardigli, Anna; Skrahina, Alena; Tortoli, Enrico; Volchenkov, Grigory; Wagner, Dirk; van der Werf, Marieke J; Williams, Bhanu; Yew, Wing-Wai; Zellweger, Jean-Pierre; Cirillo, Daniela Maria.

In: EUR RESPIR J, Vol. 44, No. 1, 01.07.2014, p. 23-63.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Transfer › peer-review

Harvard

Lange, C, Abubakar, I, Alffenaar, J-WC, Bothamley, G, Caminero, JA, Carvalho, ACC, Chang, K-C, Codecasa, L, Correia, A, Crudu, V, Davies, P, Dedicoat, M, Drobniewski, F, Duarte, R, Ehlers, C, Erkens, C, Goletti, D, Günther, G, Ibraim, E, Kampmann, B, Kuksa, L, de Lange, W, van Leth, F, van Lunzen, J, Matteelli, A, Menzies, D, Monedero, I, Richter, E, Rüsch-Gerdes, S, Sandgren, A, Scardigli, A, Skrahina, A, Tortoli, E, Volchenkov, G, Wagner, D, van der Werf, MJ, Williams, B, Yew, W-W, Zellweger, J-P & Cirillo, DM 2014, 'Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement', EUR RESPIR J, vol. 44, no. 1, pp. 23-63. https://doi.org/10.1183/09031936.00188313

APA

Lange, C., Abubakar, I., Alffenaar, J-W. C., Bothamley, G., Caminero, J. A., Carvalho, A. C. C., Chang, K-C., Codecasa, L., Correia, A., Crudu, V., Davies, P., Dedicoat, M., Drobniewski, F., Duarte, R., Ehlers, C., Erkens, C., Goletti, D., Günther, G., Ibraim, E., ... Cirillo, D. M. (2014). Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. EUR RESPIR J, 44(1), 23-63. https://doi.org/10.1183/09031936.00188313

Vancouver

Lange C, Abubakar I, Alffenaar J-WC, Bothamley G, Caminero JA, Carvalho ACC et al. Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement. EUR RESPIR J. 2014 Jul 1;44(1):23-63. https://doi.org/10.1183/09031936.00188313

Bibtex

@article{7c0b709af2de408ea898d8720f24fa76,
title = "Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement",
abstract = "The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) substantially challenges TB control, especially in the European Region of the World Health Organization, where the highest prevalence of MDR/XDR cases is reported. The current management of patients with MDR/XDR-TB is extremely complex for medical, social and public health systems. The treatment with currently available anti-TB therapies to achieve relapse-free cure is long and undermined by a high frequency of adverse drug events, suboptimal treatment adherence, high costs and low treatment success rates. Availability of optimal management for patients with MDR/XDR-TB is limited even in the European Region. In the absence of a preventive vaccine, more effective diagnostic tools and novel therapeutic interventions the control of MDR/XDR-TB will be extremely difficult. Despite recent scientific advances in MDR/XDR-TB care, decisions for the management of patients with MDR/XDR-TB and their contacts often rely on expert opinions, rather than on clinical evidence.This document summarises the current knowledge on the prevention, diagnosis and treatment of adults and children with MDR/XDR-TB and their contacts, and provides expert consensus recommendations on questions where scientific evidence is still lacking.",
author = "Christoph Lange and Ibrahim Abubakar and Alffenaar, {Jan-Willem C} and Graham Bothamley and Caminero, {Jose A} and Carvalho, {Anna Cristina C} and Kwok-Chiu Chang and Luigi Codecasa and Ana Correia and Valeriu Crudu and Peter Davies and Martin Dedicoat and Francis Drobniewski and Raquel Duarte and Cordula Ehlers and Connie Erkens and Delia Goletti and Gunar G{\"u}nther and Elmira Ibraim and Beate Kampmann and Liga Kuksa and {de Lange}, Wiel and {van Leth}, Frank and {van Lunzen}, Jan and Alberto Matteelli and Dick Menzies and Ignacio Monedero and Elvira Richter and Sabine R{\"u}sch-Gerdes and Andreas Sandgren and Anna Scardigli and Alena Skrahina and Enrico Tortoli and Grigory Volchenkov and Dirk Wagner and {van der Werf}, {Marieke J} and Bhanu Williams and Wing-Wai Yew and Jean-Pierre Zellweger and Cirillo, {Daniela Maria}",
year = "2014",
month = jul,
day = "1",
doi = "10.1183/09031936.00188313",
language = "English",
volume = "44",
pages = "23--63",
journal = "EUR RESPIR J",
issn = "0903-1936",
publisher = "European Respiratory Society",
number = "1",

}

RIS

TY - JOUR

T1 - Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement

AU - Lange, Christoph

AU - Abubakar, Ibrahim

AU - Alffenaar, Jan-Willem C

AU - Bothamley, Graham

AU - Caminero, Jose A

AU - Carvalho, Anna Cristina C

AU - Chang, Kwok-Chiu

AU - Codecasa, Luigi

AU - Correia, Ana

AU - Crudu, Valeriu

AU - Davies, Peter

AU - Dedicoat, Martin

AU - Drobniewski, Francis

AU - Duarte, Raquel

AU - Ehlers, Cordula

AU - Erkens, Connie

AU - Goletti, Delia

AU - Günther, Gunar

AU - Ibraim, Elmira

AU - Kampmann, Beate

AU - Kuksa, Liga

AU - de Lange, Wiel

AU - van Leth, Frank

AU - van Lunzen, Jan

AU - Matteelli, Alberto

AU - Menzies, Dick

AU - Monedero, Ignacio

AU - Richter, Elvira

AU - Rüsch-Gerdes, Sabine

AU - Sandgren, Andreas

AU - Scardigli, Anna

AU - Skrahina, Alena

AU - Tortoli, Enrico

AU - Volchenkov, Grigory

AU - Wagner, Dirk

AU - van der Werf, Marieke J

AU - Williams, Bhanu

AU - Yew, Wing-Wai

AU - Zellweger, Jean-Pierre

AU - Cirillo, Daniela Maria

PY - 2014/7/1

Y1 - 2014/7/1

N2 - The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) substantially challenges TB control, especially in the European Region of the World Health Organization, where the highest prevalence of MDR/XDR cases is reported. The current management of patients with MDR/XDR-TB is extremely complex for medical, social and public health systems. The treatment with currently available anti-TB therapies to achieve relapse-free cure is long and undermined by a high frequency of adverse drug events, suboptimal treatment adherence, high costs and low treatment success rates. Availability of optimal management for patients with MDR/XDR-TB is limited even in the European Region. In the absence of a preventive vaccine, more effective diagnostic tools and novel therapeutic interventions the control of MDR/XDR-TB will be extremely difficult. Despite recent scientific advances in MDR/XDR-TB care, decisions for the management of patients with MDR/XDR-TB and their contacts often rely on expert opinions, rather than on clinical evidence.This document summarises the current knowledge on the prevention, diagnosis and treatment of adults and children with MDR/XDR-TB and their contacts, and provides expert consensus recommendations on questions where scientific evidence is still lacking.

AB - The emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) substantially challenges TB control, especially in the European Region of the World Health Organization, where the highest prevalence of MDR/XDR cases is reported. The current management of patients with MDR/XDR-TB is extremely complex for medical, social and public health systems. The treatment with currently available anti-TB therapies to achieve relapse-free cure is long and undermined by a high frequency of adverse drug events, suboptimal treatment adherence, high costs and low treatment success rates. Availability of optimal management for patients with MDR/XDR-TB is limited even in the European Region. In the absence of a preventive vaccine, more effective diagnostic tools and novel therapeutic interventions the control of MDR/XDR-TB will be extremely difficult. Despite recent scientific advances in MDR/XDR-TB care, decisions for the management of patients with MDR/XDR-TB and their contacts often rely on expert opinions, rather than on clinical evidence.This document summarises the current knowledge on the prevention, diagnosis and treatment of adults and children with MDR/XDR-TB and their contacts, and provides expert consensus recommendations on questions where scientific evidence is still lacking.

U2 - 10.1183/09031936.00188313

DO - 10.1183/09031936.00188313

M3 - SCORING: Journal article

C2 - 24659544

VL - 44

SP - 23

EP - 63

JO - EUR RESPIR J

JF - EUR RESPIR J

SN - 0903-1936

IS - 1

ER -